Navigation Links
Genetic testing for breast or ovarian cancer risk may be greatly underutilized
Date:5/21/2009

Although a test for gene mutations known to significantly increase the risk of hereditary breast or ovarian cancer has been available for more than a decade, a new study finds that few women with family histories of these cancers are even discussing genetic testing with their physicians or other health care providers. In a report in the Journal of General Internal Medicine, which has been released online, investigators from the Massachusetts General Hospital (MGH) Institute of Health Policy and Dana-Farber Cancer Institute note that their findings illustrate the challenges of bringing genetic information into real-world clinical practice.

"Testing for BRCA1 and 2 mutations has been around a long time and should be a good indicator of whether genetic testing is making its way into regular medical practice," says Douglas Levy, PhD, of the MGH Institute for Health Policy, the study's lead author. "When a well-established genetic test is not being incorporated into clinical practice when appropriate, we are a long way from meeting the promise of personalized, genetically-tailored medical care."

Most women's lifetime risk of breast cancer is about 13 percent, and the risk for ovarian cancer is less than 2 percent. But women with mutations in the BRCA1 or BRCA2 genes may be 3 to 7 times more likely to develop breast cancer and 9 to 30 times more likely to develop ovarian cancer than women with unaltered forms of the genes. Several organizations have issued clinical guidelines designating who should be screened for BRCA1/2 mutations, and while there have been discrepancies among the guidelines, all of them include a history of breast or ovarian cancer in close relatives among the criteria indicating elevated risk. The authors note that most U.S. health insurers cover at least part of the cost of BRCA1/2 testing for at-risk women.

The current study analyzed data from the 2000 and 2005 National Health Interview Surveys, both of
'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2

Related biology news :

1. DNA-Prokids: Genetic identification against traffic in human beings
2. ISU researcher identifies genetic pathway responsible for much of plant growth
3. Genetic factors may predict depression in heart disease patients
4. 100 reasons to change the way we think about genetics
5. Study finds genetic links to age of first menstrual period and menopause
6. ACLU -- Myriad Genetics lawsuit will become landmark case
7. UC Riverside geneticist receives highest honor from Botanical Society of America
8. Most extensive genetic resource for reef-building coral created
9. UNC study identifies genetic cause of most common form of breast cancer
10. American College of Medical Genetics affirms importance of newborn screening dried blood spots
11. Comprehensive genetic study paves way for new blood-pressure medicines

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...re some of the Ocean,s most distinctive residents....strange head shape, says Michelle McComb from Flo...he shark,s vision. ,Perhaps their visual field has...Comb, giving the sharks excellent stereovision and...here were two schools of thought on this theory. I...
(Date:11/26/2009)...t in eight European countries has shown that closi...andemic could have a significant role in reducing ...pen access journal BMC Infectious Diseases compa... weekends/holidays, finding that they were reduced...t and Antwerp University, Belgium, led a team of E...
(Date:11/26/2009)...esistant Staphylococcus Aureus ) and other drug-r...emperature plasma prototype devices have been deve...tericidal cocktails. , Two prototype devices hav...f healthy skin (e.g. hands and feet) in hospitals ... threat; and another to shoot bacteria-killing age...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2School closure could reduce swine flu transmission by 21 percent 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3DNA Genotek Partners with Roswell Park Cancer Institute to Accelerate Breast Cancer Research 12597 1DNA Genotek Partners with Roswell Park Cancer Institute to Accelerate Breast Cancer Research 12597 2DNA Genotek Partners with Roswell Park Cancer Institute to Accelerate Breast Cancer Research 12597 3FDA Accepts Final Section of NDA Filing for LUCASSIN 28R 29 48733 1FDA Accepts Final Section of NDA Filing for LUCASSIN 28R 29 48733 2Volvo Invites Customers to Cut Their Service Bills While Supporting Pediatric Cancer Research 48729 1Volvo Invites Customers to Cut Their Service Bills While Supporting Pediatric Cancer Research 48729 2Volvo Invites Customers to Cut Their Service Bills While Supporting Pediatric Cancer Research 48729 3
...ltimore, MD) In the first neuroimaging study to e...searchers at the Kennedy Krieger Institute have un...l basis of autism. The study, published online in ...ss, compared the brain activity of children with h...ing peers while performing a simple motor tasktapp...
... biotechnologies that allow scientists to quickly ...le DNA analysis are being creatively deployed for ...isease. , The University of Ghana, supported by t... is pioneering the use of DNA "barcodes" to map me... lymphatic filariasis (LF), commonly known as elep...
...e human brain stores some kinds of memories for a ...t things, our gray matter also creates temporary m...the few seconds these visual memories exist. For d...memories don,t suddenly disappear, but grow gradua...nds. , Now researchers at the University of Calif...
Other Biology News:First neuroimaging study examining motor execution in children with autism reveals new insights 2First neuroimaging study examining motor execution in children with autism reveals new insights 3DNA barcoding of mosquito species deployed in bid to end elephantiasis 2DNA barcoding of mosquito species deployed in bid to end elephantiasis 3DNA barcoding of mosquito species deployed in bid to end elephantiasis 4Some short-term memories die suddenly, no fading 2
(Date:11/24/2009)...IK, Iceland, November 24 ...nced the approval of all of its,"first day" motion... Delaware,(the "Bankruptcy Court"). deCODE last we...pter 11 of the United States Bankruptcy Code with ... by the Bankruptcy Court allow the company to cont...
(Date:11/24/2009)...24 /PRNewswire-Asia/ -- Shanghai Biolaxy announced...(SFDA) has approved the,investigational new drug a...lin), an innovative insulin formulation to treat d...ate its first phase I clinical study. , D... glucose and poor,metabolism. The complications of...
(Date:11/24/2009)...ndpoint has been met for patients with advanced-st...EBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEtern...ompany"), a global biopharmaceutical company focus...ced positive efficacy data from a Phase 2 study wi...108 (formerly AN-152), in patients with advanced o...
(Date:11/24/2009)...2009 Arena Pharmaceutica...he company is scheduled to present at the Piper Ja...er 1, 2009 at 11:30 a.m. Eastern Time (8:30 a.m. P...ork City. Jack Lief, Arena,s President and Chief E...iew of the company, including its clinical develop...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...cts of Cost Savings Initiatives Quantified - ...dance -, HOPKINTON, Mass., April 24 Caliper Life...er of tools and services for,drug discovery and li...ented a plan to consolidate its west coast busines...improve productivity and effectiveness of,its rese...
...RY, N.J., April 24 Amicus Therapeutics,Inc. (Nasd... President and,Chief Executive Officer, will prese... Healthcare Unplugged Conference on Wednesday, Apr...in Key Biscayne, Florida., The presentation will ...icus, website at http://www.amicustherapeutics.co...
..., Pa., April 24 Cephalon, Inc.,(Nasdaq: CEPH ) t...fication,Notice Letter relating to an Abbreviated ...Food and Drug Administration (FDA) by Watson,Labor...ell a generic,version of FENTORA(R) (fentanyl bucc...leges that the U.S. Patent Numbers 6,200,604 and 6...
Other Biology Technology:Caliper Life Sciences Reports West Coast Consolidation of Operations 2Caliper Life Sciences Reports West Coast Consolidation of Operations 3Caliper Life Sciences Reports West Coast Consolidation of Operations 4Cephalon Notified of Generic Fentanyl Buccal Tablet Filing 2Cephalon Notified of Generic Fentanyl Buccal Tablet Filing 3
Goat Anti-T7 tag Polyclonal Antibody, Agarose Conjugated from GeneTex
Goat Anti-T7 Polyclonal Antibody, Agarose Conjugated from GeneTex
Rabbit Anti-Olfactory Receptor LS189744 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-C/EBPdelta Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Biology Products: